370 related articles for article (PubMed ID: 20345344)
1. Contributions of computational chemistry and biophysical techniques to fragment-based drug discovery.
Gozalbes R; Carbajo RJ; Pineda-Lucena A
Curr Med Chem; 2010; 17(17):1769-94. PubMed ID: 20345344
[TBL] [Abstract][Full Text] [Related]
2. In silico fragment-based drug design.
Konteatis ZD
Expert Opin Drug Discov; 2010 Nov; 5(11):1047-65. PubMed ID: 22827744
[TBL] [Abstract][Full Text] [Related]
3. Combining biophysical screening and X-ray crystallography for fragment-based drug discovery.
Hennig M; Ruf A; Huber W
Top Curr Chem; 2012; 317():115-43. PubMed ID: 21837555
[TBL] [Abstract][Full Text] [Related]
4. Applied Biophysical Methods in Fragment-Based Drug Discovery.
Coyle J; Walser R
SLAS Discov; 2020 Jun; 25(5):471-490. PubMed ID: 32345095
[TBL] [Abstract][Full Text] [Related]
5. Counting on Fragment Based Drug Design Approach for Drug Discovery.
Kashyap A; Singh PK; Silakari O
Curr Top Med Chem; 2018; 18(27):2284-2293. PubMed ID: 30499406
[TBL] [Abstract][Full Text] [Related]
6. Computational medicinal chemistry in fragment-based drug discovery: what, how and when.
Rabal O; Urbano-Cuadrado M; Oyarzabal J
Future Med Chem; 2011 Jan; 3(1):95-134. PubMed ID: 21428828
[TBL] [Abstract][Full Text] [Related]
7. Fragment informatics and computational fragment-based drug design: an overview and update.
Sheng C; Zhang W
Med Res Rev; 2013 May; 33(3):554-98. PubMed ID: 22430881
[TBL] [Abstract][Full Text] [Related]
8. Recombinant Kinase Production and Fragment Screening by NMR Spectroscopy.
Han B; Ahn HC
Methods Mol Biol; 2016; 1360():35-46. PubMed ID: 26501900
[TBL] [Abstract][Full Text] [Related]
9. Introduction to fragment-based drug discovery.
Erlanson DA
Top Curr Chem; 2012; 317():1-32. PubMed ID: 21695633
[TBL] [Abstract][Full Text] [Related]
10. High-Throughput Screening by Nuclear Magnetic Resonance (HTS by NMR) for the Identification of PPIs Antagonists.
Wu B; Barile E; De SK; Wei J; Purves A; Pellecchia M
Curr Top Med Chem; 2015; 15(20):2032-42. PubMed ID: 25986689
[TBL] [Abstract][Full Text] [Related]
11. Biophysical methods for identifying fragment-based inhibitors of protein-protein interactions.
Pfaff SJ; Chimenti MS; Kelly MJ; Arkin MR
Methods Mol Biol; 2015; 1278():587-613. PubMed ID: 25859978
[TBL] [Abstract][Full Text] [Related]
12. Applications of Biophysics in High-Throughput Screening Hit Validation.
Genick CC; Barlier D; Monna D; Brunner R; Bé C; Scheufler C; Ottl J
J Biomol Screen; 2014 Jun; 19(5):707-14. PubMed ID: 24695619
[TBL] [Abstract][Full Text] [Related]
13. Advances in fragment-based drug discovery platforms.
Orita M; Warizaya M; Amano Y; Ohno K; Niimi T
Expert Opin Drug Discov; 2009 Nov; 4(11):1125-44. PubMed ID: 23480433
[TBL] [Abstract][Full Text] [Related]
14. Fragment based drug design: from experimental to computational approaches.
Kumar A; Voet A; Zhang KY
Curr Med Chem; 2012; 19(30):5128-47. PubMed ID: 22934764
[TBL] [Abstract][Full Text] [Related]
15. NMR-Fragment Based Virtual Screening: A Brief Overview.
Singh M; Tam B; Akabayov B
Molecules; 2018 Jan; 23(2):. PubMed ID: 29370102
[TBL] [Abstract][Full Text] [Related]
16. Fragment-based lead discovery and design.
Joseph-McCarthy D; Campbell AJ; Kern G; Moustakas D
J Chem Inf Model; 2014 Mar; 54(3):693-704. PubMed ID: 24490951
[TBL] [Abstract][Full Text] [Related]
17. Target immobilization as a strategy for NMR-based fragment screening: comparison of TINS, STD, and SPR for fragment hit identification.
Kobayashi M; Retra K; Figaroa F; Hollander JG; Ab E; Heetebrij RJ; Irth H; Siegal G
J Biomol Screen; 2010 Sep; 15(8):978-89. PubMed ID: 20817886
[TBL] [Abstract][Full Text] [Related]
18. Mass spectrometry for fragment screening.
Chan DS; Whitehouse AJ; Coyne AG; Abell C
Essays Biochem; 2017 Nov; 61(5):465-473. PubMed ID: 28986384
[TBL] [Abstract][Full Text] [Related]
19. [Progress in the fragment-based drug discovery].
Ren J; Li J; Shi F; Wang X; He JH; Xu YC; Zhang NX; Xiong B; Shen JK
Yao Xue Xue Bao; 2013 Jan; 48(1):14-24. PubMed ID: 23600136
[TBL] [Abstract][Full Text] [Related]
20. Perspectives on Fragment-based Drug Discovery: A Strategy Applicable to Diverse Targets.
Li Q; Kang C
Curr Top Med Chem; 2021; 21(13):1099-1112. PubMed ID: 34348623
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]